Seven Eight Capital, LP Bio N Tech Se Transaction History

Seven Eight Capital, LP

  • $1.05 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 04, 2022
BUY
$123.25 - $186.24 $454,915 - $687,411
3,691 New
3,691 $550,000
Q2 2021

Aug 13, 2021
SELL
$113.32 - $241.49 $2.33 Million - $4.97 Million
-20,586 Closed
0 $0
Q4 2020

Feb 09, 2021
BUY
$72.71 - $129.54 $1.5 Million - $2.67 Million
20,586 New
20,586 $1.68 Million

Others Institutions Holding BNTX

# of Institutions
356
Shares Held
38.3M
Call Options Held
2.45M
Put Options Held
2.29M
View Full List

About BioNTech SE

BNTX Quotes by TradingView
  • Ticker BNTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 242,684,992
  • Market Cap $27.5B
  • Description
  • BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...
More about BNTX
Track This Portfolio

Track Seven Eight Capital, LP Portfolio

Follow Seven Eight Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Seven Eight Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Seven Eight Capital, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email